FCMV
CNTA

Foresite Capital Management VI’s Centessa Pharmaceuticals CNTA Stock Holding History

Foresite Capital Management VI’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.2M Hold
1,364,019
– – 11.77% 3
2025
Q4 		$34.1M Buy
1,364,019
+50,000
+4% +$1.27M 10.31% 4
2025
Q3 		$31.9M Buy
1,314,019
+60,640
+5% +$1.08M 12.31% 3
2025
Q2 		$16.5M Hold
1,253,379
– – 9.26% 2
2025
Q1 		$18M Hold
1,253,379
– – 9.87% 3
2024
Q4 		$21M Buy
+1,253,379
New +$20.8M 9.35% 3

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Foresite Capital Management VI's CNTA Position: Q1 2026 in Review

Foresite Capital Management VI held its Centessa Pharmaceuticals (CNTA) position steady in Q1 2026 at 1,364,019 shares worth $54.2M. The position accounts for 11.77% of the portfolio, ranked #3.

Foresite Capital Management VI first reported a position in CNTA in Q4 2024 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Foresite Capital Management VI held 1,364,019 shares of Centessa Pharmaceuticals worth $54.2M as of Q1 2026.
  • Foresite Capital Management VI left its Centessa Pharmaceuticals share count unchanged in Q1 2026.
  • Centessa Pharmaceuticals made up 11.77% of Foresite Capital Management VI's portfolio in Q1 2026, its #3 holding.
  • Foresite Capital Management VI first reported a position in Centessa Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Foresite Capital Management VI's 13F filing for Q1 2026, filed 15 May 2026.